Millennium Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Millennium Management’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-188,931	Closed	-$1.72M	–	4410
2018 Q1	$1.72M	Sell	188,931 -135,095	-42%	-$745K	﹤0.01%	2406
2017 Q4	$1.39M	Sell	324,026 -127,835	-28%	-$609K	﹤0.01%	2503
2017 Q3	$637K	Sell	451,861 -238,769	-35%	-$333K	﹤0.01%	2734
2017 Q2	$1.04M	Buy	690,630 +431,878	+167%	+$927K	﹤0.01%	2433
2017 Q1	$665K	Sell	258,752 -143,148	-36%	-$331K	﹤0.01%	2637
2016 Q4	$1.02M	Sell	401,900 -44,165	-10%	-$127K	﹤0.01%	2233
2016 Q3	$1.38M	Sell	446,065 -153,745	-26%	-$479K	﹤0.01%	2118
2016 Q2	$1.93M	Sell	599,810 -298,057	-33%	-$1.09M	﹤0.01%	1803
2016 Q1	$2.78M	Buy	897,867 +9,425	+1%	+$30.8K	0.01%	1605
2015 Q4	$3.56M	Buy	888,442 +32,301	+4%	+$149K	0.01%	1590
2015 Q3	$3.92M	Buy	856,141 +71,734	+9%	+$375K	0.01%	1474
2015 Q2	$4.07M	Sell	784,407 -25,225	-3%	-$151K	0.01%	1518
2015 Q1	$5.07M	Sell	809,632 -81,710	-9%	-$472K	0.01%	1404
2014 Q4	$5.61M	Buy	891,342 +99,249	+13%	+$605K	0.01%	1315
2014 Q3	$4.82M	Buy	792,093 +509,705	+180%	+$3.48M	0.01%	1314
2014 Q2	$1.86M	Buy	282,388 +182,159	+182%	+$2.05M	0.01%	1829
2014 Q1	$2.39M	Buy	+100,229	New	+$1.45M	0.01%	1653
2013 Q4	–	Sell	-24,088	Closed	-$321K	–	3945
2013 Q3	$321K	Buy	24,088 +10,492	+77%	+$166K	﹤0.01%	2826
2013 Q2	$179K	Buy	+13,596	New	+$183K	﹤0.01%	2782

Other funds holding ECYT

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management's ECYT Position: Q2 2018 in Review

Millennium Management sold out of Endocyte, Inc. Common Stock (ECYT) in Q2 2018, closing a stake of 188,931 shares — an estimated $1.72M sold.

Millennium Management first reported a position in ECYT in Q2 2013 and held it in 19 quarters. The position peaked at $5.61M in Q4 2014. 114 funds tracked by Wall St. Rank hold ECYT as of Q2 2018.

Millennium Management reported no remaining Endocyte, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Millennium Management sold 188,931 Endocyte, Inc. Common Stock shares in Q2 2018, an estimated $1.72M.
Millennium Management first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 19 quarters.
Millennium Management's Endocyte, Inc. Common Stock position peaked at $5.61M in Q4 2014.
114 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q2 2018.

Based on Millennium Management's 13F filing for Q2 2018, filed 14 Aug 2018.